Encompass Health Corporation Increase (Decrease) in Interest Payable, Net
Encompass Health Corporation (EHC) reported Increase (Decrease) in Interest Payable, Net of -$15.80 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-10-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2025-10-31
- Encompass Health Corporation increase (decrease) in interest payable, net for the quarter ending 2022-12-31 was $19.00M, a 7.32% decline year-over-year.
- Encompass Health Corporation increase (decrease) in interest payable, net for the quarter ending 2021-12-31 was $20.50M, a 37.58% increase year-over-year.
- Encompass Health Corporation increase (decrease) in interest payable, net for the quarter ending 2020-12-31 was $14.90M.
- Encompass Health Corporation increase (decrease) in interest payable, net for the quarter ending 2012-03-31 was -$5.80M, a 154.21% decline year-over-year.
- Encompass Health Corporation increase (decrease) in interest payable, net for fiscal 2022 was -$1.70M.
- Encompass Health Corporation increase (decrease) in interest payable, net for fiscal 2021 was -$2.60M, a 117.69% decline from fiscal 2020.
- Encompass Health Corporation increase (decrease) in interest payable, net for fiscal 2020 was $14.70M.
- Encompass Health Corporation increase (decrease) in interest payable, net for fiscal 2012 was $3.40M, a 240.00% increase from fiscal 2011.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 9 month as first filed | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | -$15.80M 10-Q · filed 2025-10-31 | ||||
| 2024-09-30 | -$19.20M 10-Q · filed 2025-10-31 | ||||
| 2023-09-30 | -$19.10M 10-Q · filed 2024-11-01 | ||||
| 2022-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$1.70M 10-K · filed 2023-02-27 | |||
| 2022-09-30 | -$20.70M 10-Q · filed 2023-11-01 | ||||
| 2021-12-31 | $20.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$2.60M 10-K · filed 2023-02-27 | |||
| 2021-09-30 | -$23.10M 10-Q · filed 2022-11-02 | -$23.00M 10-Q · filed 2021-11-02 | |||
| 2020-12-31 | $14.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $14.70M 10-K · filed 2023-02-27 | |||
| 2020-09-30 | -$200.00K 10-Q · filed 2021-11-02 | ||||
| 2019-09-30 | $7.40M 10-Q · filed 2020-11-02 | ||||
| 2018-09-30 | $8.20M 10-Q · filed 2019-10-31 | ||||
| 2017-09-30 | $7.30M 10-Q · filed 2018-10-31 | ||||
| 2016-09-30 | $6.00M 10-Q · filed 2017-10-31 | ||||
| 2015-09-30 | $13.90M 10-Q · filed 2016-10-28 | ||||
| 2014-09-30 | $4.70M 10-Q · filed 2015-10-29 | ||||
| 2012-12-31 | $3.40M 10-K · filed 2013-02-19 | ||||
| 2012-03-31 | -$5.80M 10-Q · filed 2012-05-01 | $11.80M derived: sum of 2 quarters · filed 2013-02-19 | -$6.80M derived: sum of 3 quarters · filed 2013-02-19 | -$15.50M derived: sum of 4 quarters · filed 2013-02-19 | |
| 2011-12-31 | $17.60M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | -$1.00M derived: sum of 2 quarters · filed 2013-02-19 | -$9.70M derived: sum of 3 quarters · filed 2013-02-19 | $1.00M 10-K · filed 2013-02-19 | |
| 2011-09-30 | -$18.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$27.30M derived: sum of 2 quarters · filed 2011-11-04 | -$16.60M 10-Q · filed 2011-11-04 | -$16.00M derived: sum of 4 quarters · filed 2013-02-19 | |
| 2011-06-30 | -$8.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $2.00M 10-Q · filed 2011-08-04 | $2.60M derived: sum of 3 quarters · filed 2013-02-19 | $10.00M derived: sum of 4 quarters · filed 2013-02-19 | |
| 2011-03-31 | $10.70M 10-Q · filed 2012-05-01 | $11.30M derived: sum of 2 quarters · filed 2013-02-19 | $18.70M derived: sum of 3 quarters · filed 2013-02-19 | $10.90M derived: sum of 4 quarters · filed 2013-02-19 | |
| 2010-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $8.00M derived: sum of 2 quarters · filed 2013-02-19 | $200.00K derived: sum of 3 quarters · filed 2013-02-19 | $14.70M 10-K · filed 2013-02-19 | |
| 2010-09-30 | $7.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$400.00K derived: sum of 2 quarters · filed 2011-11-04 | $14.10M 10-Q · filed 2011-11-04 | ||
| 2010-06-30 | -$7.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $6.70M 10-Q · filed 2011-08-04 | |||
| 2010-03-31 | $14.50M 10-Q · filed 2011-05-02 | ||||
| 2009-12-31 | -$800.00K 8-K · filed 2012-09-06 | ||||
| 2008-12-31 | -$3.60M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |